LBA20 First-line Carboplatin-Cyclophosphamide (CC) Versus Paclitaxel (P) with or Without Atezolizumab (atezo) for Metastatic Triple Negative Breast Cancer (mtnbc): Results from a Multicenter, Randomized Phase IIb Trial: the Triple-B Study (BOOG 2013-01)
Annals of Oncology(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined